Indoleamine-2,3-dioxygenase and other interferon-γ-mediated pathways in patients with human immunodeficiency virus infection

被引:51
作者
Schroecksnadel, Katharina
Zangerle, R.
Bellmann-Weiler, R.
Garimorth, K.
Weiss, G.
Fuchs, Dietmer
机构
[1] Innsbruck Med Univ, Dept Internal Med, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Dermatol & Venerol, A-6020 Innsbruck, Austria
[3] Innsbruck Med Univ, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria
关键词
D O I
10.2174/138920007780362608
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus type 1 (HIV) infection is characterized by progressive immunodeficiency despite of an overwhelming cellular immune activation. Patients show highly elevated serum/plasma concentrations of the proinflammatory cytokine interferon-gamma ((IFN-gamma)), which induces human monocytes to form neopterin, to produce reactive oxygen species (ROS) and in parallel, to degrade tryptophan. Enhanced tryptophan degradation by the enzyme indoleamine-2, 3-dioxygenase (IDO) contributes importantly to disease progression and '' complications '' of HIV infection: By a subsequent impairment of protein metabolism and serotonin formation, the development of neuropsychiatric disorders and weight loss in HIV infected patients can be enforced. Furthermore, increased IDO-activation efficiently suppresses die growth and proliferation of pathogens as well as host T-cells. IDO and other IFN-gamma-mediated pathways are strongly induced in patients with HIV infection and are also linked with disease progression: Neopterin formation by GTP-cyclohydrolase I sensitively reflects the stage of the disease, and determination of the pteridine in body fluids is useful to monitor the efficacy of intiretroviral therapy. Neopterin is an independent prognostic factor for the outcome of disease, and well suited to estimate the degree of immune activation in vivo and the responsiveness of immunocompetent cells to stimulation in vitro. ROS formation may contribute to the development of oxidative stress in HIV infection, resulting in depletion of antioxidants. The cause-effective role of an overwhelming Th1-type immune response together with the activation of IDO and other IFN-gamma-inediated biochemical pathways for the course of HIV infection, the development of immunodeficiency, anemia and weight loss in HIV patients is discussed.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 194 条
[1]  
ABRAMS B, 1993, J ACQ IMMUN DEF SYND, V6, P949
[2]   Cutting edge: The prevalence of regulatory T cells lymphoid tissue is correlated with viral load HIV-infected patients [J].
Andersson, J ;
Boasso, A ;
Nilsson, J ;
Zhang, R ;
Shire, NJ ;
Lindback, S ;
Shearer, GM ;
Chougnet, CA .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3143-3147
[3]   Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals - Correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels [J].
Andersson L.M. ;
Hagberg L. ;
Fuchs D. ;
Svennerholm B. ;
Gisslén M. .
Journal of NeuroVirology, 2001, 7 (6) :542-547
[4]   CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses [J].
Arrode, G ;
Finke, JS ;
Zebroski, H ;
Siegal, FP ;
Steinman, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :159-170
[5]   Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches [J].
Asnis, GM ;
De La Garza, R .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) :322-335
[6]   7,8-dihydroneopterin upregulates interferon-gamma promoter in T cells [J].
BaierBitterlich, G ;
Fuchs, D ;
Wachter, H .
IMMUNOBIOLOGY, 1996, 196 (04) :350-355
[7]   trans-activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro [J].
BaierBitterlich, G ;
Fuchs, D ;
Zangerle, R ;
Baeuerle, PA ;
Werner, ER ;
Fresser, F ;
Uberall, F ;
Baier, G ;
Wachter, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (02) :173-178
[8]  
BASS HZ, 1992, J ACQ IMMUN DEF SYND, V5, P215
[9]  
Bender D.A., 1986, PROGR TRYPTOPHAN SER, P159
[10]   INTERFERON-GAMMA - MECHANISM OF ACTION AND THERAPEUTIC POTENTIAL [J].
BILLIAU, A ;
DIJKMANS, R .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1433-1439